Researchers have developed a prototype injectable paste that could help restore breast volume after tumor removal, with less scarring and shorter healing time than current options.
Mobile Stroke Units, equipped with a CT scanner, point-of-care laboratory, and communications capabilities, could reduce unnecessary emergency department transfers by 86%, a new study finds.
Researchers have discovered that low physical activity is associated with a higher risk of lymphedema. They have also noted that a lymph scanner objectively measures changes in the condition.
Cardiovascular disease and depression do not co-occur by chance; the TO_AITION project aims to enable earlier diagnosis of comorbidity, better risk prediction and personalised treatment strategies.
After T-cell redirecting therapies, patients are typically hospitalized for several days to watch for side effects. New research shows that these patients can safely be monitored at home.
New immunotherapies are effective against skin cancer, but they can cause serious side effects. New insights suggest that a lower dosage may lead to better outcomes and longer survival.
A European consortium has developed a new decision making framework for health professionals which they hope will transform the care of patients with chronic obstructive pulmonary disease (COPD).
NaoTrac is a fully autonomous surgical navigation robot designed to enhance precision, safety, and efficiency in neurosurgery. By integrating advanced technologies with the expertise of surgeons, NaoTrac streamlines surgical workflows, shortens the learning curve, and improves patient outcomes.
Bioptron Hyperlight Therapy is a certified medical device that uses a patented form of polarized, polychromatic, non-coherent light. The therapy works by delivering specific light characteristics, which stimulate local blood microcirculation, enhance cellular regenerative process, decrease pain and stimulate immune system. This non-invasive and painless photobiomodulation method is clinically…
New hope for patients with neurological diseases: A combination of focused ultrasound and gene therapy enables targeted, nonsurgical control of seizure-relevant brain regions.
Most patients with metastatic colorectal cancer do not respond to immunotherapy—but why? A new study shows how the tumours block the immune system through two complementary mechanisms.
Not all PCOS is the same: Researchers identified four subgroups with distinct symptoms and different responses to treatment – opening the door to precision medicine for millions of women worldwide.
Many doctors shy away from discussing the aspect of a treatment's sustainability with their patients, expecting a negative reaction. Now, a new study suggests that these fears may be unfounded.
Breast cancer survivors are often discouraged from undergoing hormone replacement therapy (HRT) to alleviate menopause symptoms. Now, new research paints a more differentiated picture.
University of Stuttgart scientists develop enhanced CRISPR technique that makes genetic loss-of-function analyses more efficient and reproducible for medical research.
The number of patients with substance abuse disorders who are admitted to hospitals as inpatients has been steadily increasing. Hospitalists attending SHM Converge 2025, the annual meeting of the Society of Hospital Medicine (SHM) in Las Vegas this spring, were given practical advice on how to treat these patients.
German researchers discover how HIV selects genome integration targets using RNA:DNA hybrids as guides, revealing new therapeutic approaches for controlling viral reservoirs.
People with both type 2 diabetes and obstructive sleep apnoea have a higher risk of death, but treatment with CPAP may reduce that risk by around 26%, a new study finds.
In metastatic EGFR-mutated non-small cell lung cancer (NSCLC), targeting residual disease through surgery can extend the benefits of EGFR TKI therapy beyond standard monotherapy, a new study finds.
